"Fluoroquinolones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of QUINOLONES with at least one fluorine atom and a piperazinyl group.
Descriptor ID |
D024841
|
MeSH Number(s) |
D03.633.100.810.835.322
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fluoroquinolones".
Below are MeSH descriptors whose meaning is more specific than "Fluoroquinolones".
This graph shows the total number of publications written about "Fluoroquinolones" by people in this website by year, and whether "Fluoroquinolones" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 1 | 1 | 2 |
2000 | 0 | 1 | 1 |
2001 | 0 | 1 | 1 |
2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fluoroquinolones" by people in Profiles.
-
Increasing prevalence of a fluoroquinolone resistance mutation amongst Campylobacter jejuni isolates from four human infectious intestinal disease studies in the United Kingdom. PLoS One. 2020; 15(1):e0227535.
-
In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus. Antimicrob Agents Chemother. 2001 Mar; 45(3):938-42.
-
Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory season. Antimicrob Agents Chemother. 2000 Feb; 44(2):462-6.
-
Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolones. Antimicrob Agents Chemother. 1999 Oct; 43(10):2513-6.
-
Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins. Antimicrob Agents Chemother. 1999 Aug; 43(8):2051-5.